We also show that this assay was highly specific for detecting MDM2 amplification in the circulation of patients with DDLPS, as this aberration was not detectable in cell-free DNA of patients with lipoma, pleomorphic liposarcoma, undifferentiated sarcoma or LMS. Here, MDM2 is linked to pleomorphic liposarcoma.